{"name": "CyDex Pharmaceuticals",
 "permalink": "cydex-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/cydex-pharmaceuticals",
 "homepage_url": "http://www.cydexpharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "cdinfo@cydexpharma.com",
 "phone_number": "913.685.8850",
 "description": "",
 "created_at": "Thu Jan 27 03:56:45 UTC 2011",
 "updated_at": "Tue Aug 09 18:08:40 UTC 2011",
 "overview": "\u003Cp\u003ECyDex Pharmaceuticals, Inc., a pharmaceutical company, engages in the development and commercialization of drugs specifically designed to address limitations of current therapies. It develops a portfolio of product candidates utilizing its drug formulation technology using Captisol, a group of cyclodextrins. The company\u00e2\u20ac\u2122s products include Geodon IM and Abilify Injection IM for bipolar disorder/schizophrenia; Vfend IV for antifungal; and Cerenia for canine motion sickness. It also develops Fosphenytoin IV and IM for status epilepticus; Melphalan IV for multiple myeloma; Topiramate IV for epilepsy; Amiodarone IV for arrhythmia; Budesonide Solution Inhalation for asthma; Clopidogrel IV for atherothrombosis; and Budesonide/Azelastine Nasal Spray for allergic rhinitis. In addition, the company out license its technology to third parties for use in the development of their products. CyDex Pharmaceuticals, Inc. was formerly known as CyDex, Inc. and it changed its name in November 2007. The company was founded in 1993 and is based in Lenexa, Kansas.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       44],
      "assets/images/resized/0011/9169/119169v1-max-150x150.png"],
     [[213,
       63],
      "assets/images/resized/0011/9169/119169v1-max-250x250.png"],
     [[213,
       63],
      "assets/images/resized/0011/9169/119169v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Allen",
      "last_name": "K. Roberson",
      "permalink": "allen-k-roberson",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 31200000.0,
   "price_currency_code": "USD",
   "term_code": "cash",
   "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020110127e71r0002t\u0026r=Rss\u0026s=DJFVLS",
   "source_description": "Ligand Pharma Buys CyDex For $31.2M Upfront In Cash  ",
   "acquired_year": 2011,
   "acquired_month": 1,
   "acquired_day": 27,
   "acquiring_company":
    {"name": "Ligand Pharmaceuticals",
     "permalink": "ligand-pharmaceuticals",
     "image":
      {"available_sizes":
        [[[150,
           52],
          "assets/images/resized/0005/9433/59433v1-max-150x150.jpg"],
         [[250,
           87],
          "assets/images/resized/0005/9433/59433v1-max-250x250.jpg"],
         [[264,
           92],
          "assets/images/resized/0005/9433/59433v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "10513 W. 84th Terrace",
    "address2": "",
    "zip_code": "66214 ",
    "city": "Lenexa",
    "state_code": "KS",
    "country_code": "USA",
    "latitude": null,
    "longitude": null},
   {"description": "",
    "address1": "",
    "address2": "",
    "zip_code": "",
    "city": "",
    "state_code": null,
    "country_code": "CHN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}